Percutaneous Radiofrequency Ablation of Small Renal Tumors Using CT-Guidance A Review and its Current Role
Purpose: To provide key evidence-based strategies to improve outcomes of radiofrequency ablation and limit recurrences of small renal tumors.Materials and Methods: The literature was searched via OvidSP MEDLINE from 1997 to current using MeSH terms. All levels of evidence and types of reports were r...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences
2012-11-01
|
| Series: | Urology Journal |
| Subjects: | |
| Online Access: | http://www.urologyjournal.org/index.php/uj/article/view/1789/681 |
| Summary: | Purpose: To provide key evidence-based strategies to improve outcomes of radiofrequency ablation and limit recurrences of small renal tumors.Materials and Methods: The literature was searched via OvidSP MEDLINE from 1997 to current using MeSH terms. All levels of evidence and types of reports were reviewed.Results: We comprehensively reviewed technical issues, mechanisms, imaging criteria, ablative success, enhancement within one month, contraindications, oncological efficacy, morbidity rates, and follow-up strategies.Conclusion: The technique is safe and effective. Tumors < 2.5 cm are statistically most likely to remain disease-free. Anterior tumors are contraindicated. Strict follow-up is needed to detect failures, most of which occur within 3 months and can be easily salvaged with repeat radiofrequency ablation. Homogeneous enhancement within 1 month is not necessarily a failure, and tends to disappear after 4 to 6 weeks. Multi-disciplinary meetings must occur to discuss each case prior to treatment. |
|---|---|
| ISSN: | 1735-1308 1735-546X |